Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology

JAMA Oncol. 2017 Jul 1;3(7):996-998. doi: 10.1001/jamaoncol.2016.4983.

Abstract

This study compares reports from 2 next-generation sequencing tests to determine the level of concordance between platforms.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cell-Free Nucleic Acids / analysis
  • Exons
  • Female
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / genetics*
  • Reproducibility of Results
  • Sequence Analysis, DNA / methods*

Substances

  • Cell-Free Nucleic Acids